WHO Advises Doctors Not to Use Gilead’s Remdesivir for Covid


The World Health Organization recommended against using Gilead Sciences Inc.’s remdesivir to treat hospitalized Covid-19 patients less than a month after U.S. regulators granted the drug a speedy approval.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *